Telotristat Ethyl
LX1606.1-111-HEP
Phase 1 small_molecule completed
Quick answer
Telotristat Ethyl for Hepatic Impairment is a Phase 1 program (small_molecule) at LEXICON PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- LEXICON PHARMACEUTICALS, INC.
- Indication
- Hepatic Impairment
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed